Premium
Quality reporting in postchemotherapy retroperitoneal lymph node dissection
Author(s) -
Daneshmand Siamak
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33066
Subject(s) - retroperitoneal lymph node dissection , medicine , dissection (medical) , testicular cancer , germ cell tumors , lymph node , retroperitoneal space , surgery , radiology , general surgery , chemotherapy
Surgical resection of residual masses after chemotherapy remains a critical component of the management of patients with metastatic germ cell tumors. There are clear indications for postchemotherapy retroperitoneal lymph node dissection (PC‐RPLND), which remains one of the most challenging procedures urologists perform. In their article in this issue of Cancer , Umbreit et al report their institutional intraoperative and postoperative complications during PC‐RPLND using a validated tool.